Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 08-Aug-24 4:10 PM View:  | Alnylam Pharmaceuticals Inc. (ALNY) | 06-Aug-24 | Option Exercise | 20,250 | $119.68 | $2,423,450.00 | 557% 3.64K to 23.89K | |
| 08-Aug-24 4:10 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 06-Aug-24 | Planned Option Sale | 20,250 | $262.00 | $5,305,590.00 | (85%) 23.89K to 3.64K | |
| 27-Feb-23 4:11 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 23-Feb-23 | Option Exercise | 136 | -- | -- | 4% 3.5K to 3.64K | |
| 23-Nov-22 4:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 21-Nov-22 | Option Exercise | 22,500 | $71.10 | $1,599,640.00 | 643% 3.5K to 26.0K | |
| 23-Nov-22 4:05 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 21-Nov-22 | Planned Option Sale | 22,500 | $220.00 | $4,950,000.00 | (87%) 26.0K to 3.5K | |
| 14-Mar-18 7:40 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Mar-18 | Option Exercise | 17,117 | $59.82 | $1,023,940.00 | 489% 3.5K to 20.62K | |
| 14-Mar-18 7:40 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 13-Mar-18 | Market Option Sale (Planned) | 17,117 | $150.00 | $2,567,550.00 | (83%) 20.62K to 3.5K | 44% |
| 03-Nov-17 8:14 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 02-Nov-17 | Option Exercise | 20,000 | $30.09 | $601,800.00 | 571% 3.5K to 23.5K | |
| 03-Nov-17 8:14 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 02-Nov-17 | Market Option Sale (Planned) | 20,000 | $130.00 | $2,600,000.00 | (85%) 23.5K to 3.5K | 36% |
| 23-Apr-15 4:43 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 21-Apr-15 | Market Sale (Planned) | 8,165 | $130.02 | $1,061,610.00 | (70%) 11.66K to 3.5K | 36% |
| 19-Mar-15 6:44 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 19-Mar-15 | Market Sale (Planned) | 5,000 | $120.00 | $600,000.00 | (30%) 16.66K to 11.66K | 30% |
| 06-Mar-15 4:18 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 05-Mar-15 | Option Exercise | 706 | $63.86 | $45,085.20 | 4% 16.66K to 17.37K | |
| 06-Mar-15 4:18 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 05-Mar-15 | Market Option Sale (Planned) | 706 | $115.00 | $81,190.00 | (4%) 17.37K to 16.66K | 27% |
| 10-Dec-14 4:33 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 08-Dec-14 | Option Exercise | 15,000 | $30.09 | $451,350.00 | 90% 16.66K to 31.66K | |
| 10-Dec-14 4:33 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 08-Dec-14 | Market Option Sale (Planned) | 15,000 | $108.33 | $1,625,000.00 | (47%) 31.66K to 16.66K | 23% |
| 13-Nov-14 10:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 11-Nov-14 | Option Exercise | 5,000 | $30.09 | $150,450.00 | 30% 16.66K to 21.66K | |
| 13-Nov-14 10:00 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 11-Nov-14 | Market Option Sale (Planned) | 5,000 | $100.00 | $500,000.00 | (23%) 21.66K to 16.66K | 16% |
| 24-Oct-14 4:14 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Oct-14 | Option Exercise | 5,000 | $30.09 | $150,450.00 | 30% 16.66K to 21.66K | |
| 24-Oct-14 4:14 PM View: | Alnylam Pharmaceuticals Inc. (ALNY) | 22-Oct-14 | Market Option Sale (Planned) | 5,000 | $90.00 | $450,000.00 | (23%) 21.66K to 16.66K | 7% |
| 19-Oct-09 4:13 PM View: | Pfizer Inc. (PFE) | 15-Oct-09 | Grant | 887 | -- | -- | 60% 1.48K to 2.36K |